Early adopters share how premium lenses are shaping the future of patient care.
Director of Cornea and Ocular Surface Disease, Center For Sight/US Eye, Sarasota, Florida
Cataract, refractive, and corneal surgeon
priya.m.mathews@gmail.com;
Twitter @n8radcliffe
Financial disclosure: Speaker and consultant (Johnson & Johnson Vision, RxSight)
Assistant Medical Director and Director of Refractive Surgery, Center for Sight and US Eye, Sarasota, Florida
joaquin.derojas@gmail.com
X @JdeRojasMD
Financial disclosure: Consultant and speaker (Johnson & Johnson Vision, RxSight), Consultant and researcher (Lensar), Investigator (Johnson & Johnson Vision)
Founder and Medical Director, Waring Vision Institute, Mount Pleasant, South Carolina
gwaring@waringvision.com
Financial disclosure: Consultant (Johnson & Johnson Vision)
Leaders in glaucoma care discuss the transformative impact of minimally invasive glaucoma surgery and point to the benefits of an early intervention mindset.
Assistant Clinical Professor of Ophthalmology, Mount Sinai School of Medicine, New York
drradcliffe@gmail.com;
Twitter @n8radcliffe
Financial disclosure: Consultant (AbbVie/Allergan, Alcon, Bausch + Lomb, BVI Medical, Belkin Laser, Elios Vision, Nova Eye, Glaukos, Iantreck, Iridex, Lumenis Vision, New World Medical, Sight Sciences, ViaLase)
Private practice, Advanced Vision Care, Los Angeles
saharbedrood@gmail.com
Financial disclosure: Consultant (Abbvie/Allergan, Alcon, Glaukos, Theá Laboratories, Nova-Eye, BVI Medical, Elios Vision)
Cornea, glaucoma, cataract, and refractive surgery specialist, Vance Thompson Vision, Sioux Falls, South Dakota
justin.schweitzer@vancethompsonvision.com
Financial disclosure: Consultant (Abbvie/Allergan, Alcon, Glaukos, Sight Sciences, Theá)